Monotherapy with tadalafil or tamsulosin for moderate-to-severe lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from an international, double-blind, placebo-controlled trial

被引：0

作者：

Oelke, M. ^{[1
]}

Giuliano, F. ^{[2
]}

Mirone, V ^{[3
]}

Xu, L. ^{[4
]}

Cox, D. ^{[4
]}

Viktrup, L. ^{[4
]}

机构：

[1] Hannover Med Sch, Dept Urol, Hannover, NH, Germany

[2] Versailles St Quentin Univ, R Poincare Hosp, Dept Neurourol Androl, Garches, France

[3] Univ Naples Federico 2, Dept Obstetr Gynaecol Sci & Reprod Med, Naples, Italy

[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E641 / U375

页数：2

共 50 条

[41] Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study
Singh, Iqbal
Aravind, T. K.
Gupta, Sanjay
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (08)
[42] Effect of doxazosin on the symptoms of benign prostatic hyperplasia: Results from three double-blind placebo-controlled studies
Mobley, DF
Kaplan, S
Ice, K
Gaffney, M
Dias, N
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1997, 51 (05) : 282 - 288
[43] Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial REPLY
Pinggera, Germar-Michael
UROLOGY, 2014, 84 (02) : 420 - 420
[44] Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial COMMENT
Ganpule, Arvind P.
Desai, Mahesh
UROLOGY, 2014, 84 (02) : 419 - 420
[45] Re: Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial
Kaplan, Steven A.
JOURNAL OF UROLOGY, 2015, 193 (05): : 1592 - 1593
[46] Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)
Yu, Hong-Jeng
Lin, Alex Tong-Long
Yang, Stephen Shei-Dei
Tsui, Ke-Hung
Wu, Hsi-Chin
Cheng, Chen-Li
Cheng, Hong-Lin
Wu, Tony T.
Chiang, Po-Hui
BJU INTERNATIONAL, 2011, 108 (11) : 1843 - 1848
[47] Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia A study protocol for a randomized, double-blind, placebo-controlled trial
Song, Jungbin
Lee, Seung Hwan
Kim, Hocheol
MEDICINE, 2019, 98 (45) : e17848
[48] Urodynamic effects of doxazosin in men with lower urinary tract symptoms and benign prostatic obstruction - Results from three double-blind placebo-controlled studies
Abrams, P
EUROPEAN UROLOGY, 1997, 32 (01) : 39 - 46
[49] Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Richard Berges
Klaus Höfner
Michael Gedamke
Matthias Oelke
World Journal of Urology, 2014, 32 : 1163 - 1170
[50] α1-adenoceptor antagonists for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: State of the art
Djavan, B
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 23 - 30

← 1 2 3 4 5 →